One of the Swiss pharmaceutical companies has started producing a new medicine called “Medicine of Qur'ân” which allows the treatment of cataract without surgery. As the newspaper Ar-Raya, published in Qatar writes, “this drug which was synthesised by an Egyptian doctor Abdul Basit Muhammad from the secretions of human sweat glands and has an effectiveness of 99 per cent with absolutely no side effects, was registered in Europe and the United States. It is also reported that one of the Swiss companies produces the new drug in the form of liquid and eye drops.

The source of inspiration is Surah Yusuf. Dr Abdul Basit Muhammad emphasised that he obtained his inspiration from Surah Yusuf and said: “ Once in the morning, I was reading Surah Yusuf. My attention lingered over the 84th and successive ayats (verses). They tell that Prophet Yakub who was mourning his son Yusuf (peace be upon them) in sadness and grief got his eyes turned white and later when people cast over the sorrowful father’s face, the shirt of his son Yusuf, vision returned to him and he was able to see again. Here I started pondering. What could be there in the shirt of Yusuf? 

Finally I arrived at the decision that nothing except sweat could be on it. I concentrated my thoughts over the sweat and its composition. Then I proceeded to the laboratory for research.

I carried out a series of experiments on rabbits. The results turned out to be positive. Later I performed treatment on 250 patients by administering the drug twice a day for two weeks. Finally I achieved 99 per cent success and said to myself: “ This is the miracle of the Qur'ân” 

Dr Abdul Basit Muhammad presented the results of his research to appropriate institutions in Europe and the United States dealing with patenting of new discoveries for consideration. After tests and research were performed, he finalised a contract with a Swiss company on the production of the medicine on the condition that the package should clearly mention-“Medicine of Qur'ân.” 

In the words of the Egyptian scientist, the company accepted his condition and started producing the new drug.

(Courtesy-Ar-Raya, Qatar)